These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9452776)

  • 41. Nitric oxide levels in patients with atheromatous carotid plaque.
    Terzuoli L; Marinello E; Frosi B; Ciari I; Porcelli B
    Biomed Pharmacother; 2008 Jun; 62(5):325-7. PubMed ID: 18023134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?
    Chirkov YY; Horowitz JD
    Pharmacol Ther; 2007 Nov; 116(2):287-305. PubMed ID: 17765975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
    Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
    Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Endothelial dysfunction as a primary disorder in vascular diseases].
    Irribarra V; Germain A; Cuevas A; Faúndez L; Valdés G
    Rev Med Chil; 2000 Jun; 128(6):659-70. PubMed ID: 11016067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro study of endothelium-dependent relaxation and contraction of human atherosclerotic femoral artery].
    Mohácsi A; Kozlovszky B; Seres I; Csabina S; Paragh G; Boda J; Fülöp T
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2311-6. PubMed ID: 9340578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycyrrhetinic acid-sensitive mechanism does not make a major contribution to non-prostanoid, non-nitric oxide mediated endothelium-dependent relaxation of rat mesenteric artery in response to acetylcholine.
    Tanaka Y; Otsuka A; Tanaka H; Shigenobu K
    Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):227-39. PubMed ID: 10509734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular smooth muscle cell dysfunction in patients with migraine.
    Napoli R; Guardasole V; Zarra E; Matarazzo M; D'Anna C; Saccà F; Affuso F; Cittadini A; Carrieri PB; Saccà L
    Neurology; 2009 Jun; 72(24):2111-4. PubMed ID: 19528518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial dysfunction: a comprehensive appraisal.
    Esper RJ; Nordaby RA; Vilariño JO; Paragano A; Cacharrón JL; Machado RA
    Cardiovasc Diabetol; 2006 Feb; 5():4. PubMed ID: 16504104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide and endothelins: novel autocrine/paracrine regulators of the circulation.
    Marsden PA; Brenner BM
    Semin Nephrol; 1991 Mar; 11(2):169-85. PubMed ID: 2034925
    [No Abstract]   [Full Text] [Related]  

  • 53. Endothelial nitric oxide and cardiovascular disease.
    Wennmalm A
    J Intern Med; 1994 Apr; 235(4):317-27. PubMed ID: 8151263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of nitric oxide (formerly endothelium-derived relaxing factor-EDRF) in vasodilatation and vasodilator therapy.
    Tibballs J
    Anaesth Intensive Care; 1993 Dec; 21(6):759-73. PubMed ID: 8122732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A new agent--nitric oxide].
    Schreiber V
    Vnitr Lek; 1992 Sep; 38(9):833-6. PubMed ID: 1481381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control of the circulation by vasoactive mediators from endothelial cells.
    Vane JR; Botting RM
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):1-8. PubMed ID: 8032711
    [No Abstract]   [Full Text] [Related]  

  • 57. Endothelium-dependent regulation of the cardiovascular system.
    Shimokawa H; Takeshita A
    Intern Med; 1995 Oct; 34(10):939-46. PubMed ID: 8563093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relaxing factors of endothelial origin and coronary spasm].
    Vanhoutte PM; Mombouli JV; Shimokawa H
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():11-21. PubMed ID: 2111682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bradykinin and cerebral circulation: selective non-receptor interaction with histamine and serotonin through the system of nitric oxide.
    Carmignani M; Sicuteri F; Nicolodi M; Volpe AR
    Int J Clin Pharmacol Res; 1997; 17(2-3):89-92. PubMed ID: 9403361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The discovery of nitric oxide and its role in vascular biology.
    Moncada S; Higgs EA
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S193-201. PubMed ID: 16402104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.